|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
388554614 |
| 003 |
DE-627 |
| 005 |
20230428162712.0 |
| 007 |
tu |
| 008 |
040610s2004 xxk||||| 00| ||eng c |
| 035 |
|
|
|a (DE-627)388554614
|
| 035 |
|
|
|a (DE-599)GBV388554614
|
| 035 |
|
|
|a (OCoLC)177316672
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-GB
|
| 060 |
|
0 |
|a QW 920
|
| 084 |
|
|
|a 44.93
|2 bkl
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 245 |
1 |
0 |
|a Ciclosporin in the management of psoriasis: an international consensus statement
|c guest ed.: U. Mrowietz
|
| 264 |
|
1 |
|a Oxford
|b Blackwell
|c 2004
|
| 300 |
|
|
|a 23 S.
|b Ill., graf. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a The British journal of dermatology
|a Supplement
|v 67
|
| 650 |
|
2 |
|a Cyclosporins
|x therapeutic use
|
| 650 |
|
2 |
|a Psoriasis
|
| 655 |
|
7 |
|a Konferenzschrift
|0 (DE-588)1071861417
|0 (DE-627)826484824
|0 (DE-576)433375485
|2 gnd-content
|
| 700 |
1 |
|
|a Mrowietz, Ulrich
|0 (DE-588)110894065
|0 (DE-627)500675058
|0 (DE-576)169245136
|4 oth
|
| 830 |
|
4 |
|a The British journal of dermatology / Supplement
|v 67
|9 6700
|w (DE-627)129568155
|w (DE-576)015041832
|w (DE-600)224326-X
|x 0366-077X
|7 ns
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a ISIL_DE-18
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_22_i06404
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a ISIL_DE-7
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a ISIL_DE-28
|
| 912 |
|
|
|a GBV_ILN_74
|
| 912 |
|
|
|a ISIL_DE-354
|
| 912 |
|
|
|a GBV_ILN_105
|
| 912 |
|
|
|a ISIL_DE-841
|
| 936 |
b |
k |
|a 44.93
|j Dermatologie
|0 (DE-627)106410040
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|0 (DE-627)106409689
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 22
|1 01
|x 0018
|b 65298665X
|c 00
|f 18/64
|d Med X/45: Suppl 67
|e b
|j --%%--
|y zi06404
|z 22-06-04
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 1455020117
|c 00
|f Mag
|d 4 Z 6948 :Suppl. 67
|e b
|j --%%--
|y z
|z 28-01-14
|
| 980 |
|
|
|2 40
|1 01
|x 0007
|b 738054305
|c 00
|f --%%--
|d Bestellung über Zeitschriftentitel
|e f
|j --%%--
|k Bestellen / Vormerken? Suchen Sie die Signatur ZB 86201; bestellen Sie dort den Band 150
|y xsn
|z 28-09-05
|
| 980 |
|
|
|2 62
|1 01
|x 0028
|b 879675365
|c 00
|f 28/BB4-MAG
|d angebunden an: ZA 3916 (150,2,Suppl.)
|e b
|j --%%--
|y rbb4d
|z 25-06-08
|
| 980 |
|
|
|2 74
|1 01
|x 0354
|b 653994702
|c 00
|f --%%--
|d Z 3054a-67
|e u
|j --%%--
|k Bestellen mit Titel und Bandzählung von: British journal of dermatology. Supplement
|y zb
|z 25-06-04
|
| 980 |
|
|
|2 105
|1 01
|x 0841
|b 670152226
|c 00
|f Mag
|d 1139aAZ:67
|e u
|j --%%--
|y z
|z 21-10-04
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 00
|a Psoriasis-drug therapy
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 01
|a Cyclosporine-therapeutic use
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 50
|a Congresses
|
| 982 |
|
|
|2 74
|1 00
|x DE-354
|8 51
|a Consensus Development Conference
|
| 983 |
|
|
|2 105
|1 00
|x DE-841
|8 00
|a MN 450
|
| 984 |
|
|
|2 22
|1 01
|x 0018
|a 056675674
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 27$027775720
|
| 984 |
|
|
|2 105
|1 01
|x 0841
|a 841$000055104X
|
| 985 |
|
|
|2 22
|1 01
|x 0018
|a uke2004.1415
|
| 985 |
|
|
|2 62
|1 01
|x 0028
|a 28/041
|
| 985 |
|
|
|2 62
|1 01
|x 0028
|a ZA 3916 (150,2,Suppl.)
|
| 985 |
|
|
|2 74
|1 01
|x 0354
|a Z 3054a-67
|
| 985 |
|
|
|2 105
|1 01
|x 0841
|a 1139aAZ:67
|
